These outcomes, along with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the notion of concentrating on ACKR3 as a novel approach to modulate the opioid technique, which could open up new therapeutic avenues for opioid-similar Diseases.Together with the explained earlier me